Optical vector analysis has emerged as a critical tool for characterising optical devices, enabling simultaneous measurement of amplitude and phase responses over wide bandwidths. This technique is ...

Even though it will likely be another year until the adoption of Wi-Fi 8, also known as IEEE 802.11bn, first router ...

All-optical image processing has been viewed as a promising technique for its high computation speed and low power ...

A device smaller than a grain of dust is emerging as a surprisingly powerful candidate to reshape how quantum computers are ...

Cancer researchers have long treated genetic chaos and epigenetic rewiring as separate engines of disease, two parallel ...

Lysoway Therapeutics, Inc., a biotechnology company advancing structure-guided small-molecule modulators of lysosomal ion channels to treat age-related neurodegeneration, today announced that its lead ...

TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...

Lysoway Therapeutics, Inc., a biotechnology company advancing structure-guided small-molecule modulators of lysosomal ion ...

In the expanding field of peptide-based research, a combination of two bioactive molecules—BPC‑157 and TB‑500—has garnered ...

No treatment-related adverse toxicity was observed across completed GLP studies, with consistent systemic exposure following ...

Is it karma? Coincidence? Either way, the ghost of the dot-com bubble is back 25 years later.

Solvonis Therapeutics plc (LSE: SVNS), an emerging biopharmaceutical company developing novel medicines for high-burden central nervous system ("CNS") disorders, announces that it has received a ...